258 related articles for article (PubMed ID: 19103203)
1. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia.
Leedham SJ; Graham TA; Oukrif D; McDonald SA; Rodriguez-Justo M; Harrison RF; Shepherd NA; Novelli MR; Jankowski JA; Wright NA
Gastroenterology; 2009 Feb; 136(2):542-50.e6. PubMed ID: 19103203
[TBL] [Abstract][Full Text] [Related]
2. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
[TBL] [Abstract][Full Text] [Related]
3. Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis.
Galandiuk S; Rodriguez-Justo M; Jeffery R; Nicholson AM; Cheng Y; Oukrif D; Elia G; Leedham SJ; McDonald SA; Wright NA; Graham TA
Gastroenterology; 2012 Apr; 142(4):855-864.e8. PubMed ID: 22178590
[TBL] [Abstract][Full Text] [Related]
4. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.
Yoshida T; Mikami T; Mitomi H; Okayasu I
J Pathol; 2003 Feb; 199(2):166-75. PubMed ID: 12533829
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.
Rapozo DC; Grinmann AB; Carvalho AT; de Souza HS; Soares-Lima SC; de Almeida Simão T; de Paiva D; Abby F; Albano RM; Pinto LF
Int J Colorectal Dis; 2009 Oct; 24(10):1141-8. PubMed ID: 19543899
[TBL] [Abstract][Full Text] [Related]
6. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
[TBL] [Abstract][Full Text] [Related]
7. Integrative approach for prioritizing cancer genes in sporadic colon cancer.
Reid JF; Gariboldi M; Sokolova V; Capobianco P; Lampis A; Perrone F; Signoroni S; Costa A; Leo E; Pilotti S; Pierotti MA
Genes Chromosomes Cancer; 2009 Nov; 48(11):953-62. PubMed ID: 19672874
[TBL] [Abstract][Full Text] [Related]
8. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
[TBL] [Abstract][Full Text] [Related]
9. DNA alterations of microsatellite DNA, p53, APC and K-ras in Chinese colorectal cancer patients.
Xu XM; Qian JC; Cai Z; Tang T; Wang P; Zhang KH; Deng ZL; Cai JP
Eur J Clin Invest; 2012 Jul; 42(7):751-9. PubMed ID: 22324744
[TBL] [Abstract][Full Text] [Related]
10. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
Chaubert P; Benhattar J; Saraga E; Costa J
Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
[TBL] [Abstract][Full Text] [Related]
13. A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.
Scholtka B; Schneider M; Melcher R; Katzenberger T; Friedrich D; Berghof-Jäger K; Scheppach W; Steinberg P
Cancer Epidemiol; 2009 Aug; 33(2):123-9. PubMed ID: 19679059
[TBL] [Abstract][Full Text] [Related]
14. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
16. Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas.
Thirlwell C; Will OC; Domingo E; Graham TA; McDonald SA; Oukrif D; Jeffrey R; Gorman M; Rodriguez-Justo M; Chin-Aleong J; Clark SK; Novelli MR; Jankowski JA; Wright NA; Tomlinson IP; Leedham SJ
Gastroenterology; 2010 Apr; 138(4):1441-54, 1454.e1-7. PubMed ID: 20102718
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.
Yoshida T; Matsumoto N; Mikami T; Okayasu I
Br J Cancer; 2004 Sep; 91(6):1081-8. PubMed ID: 15292938
[TBL] [Abstract][Full Text] [Related]
18. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.
Fujii S; Fujimori T; Kawamata H; Takeda J; Kitajima K; Omotehara F; Kaihara T; Kusaka T; Ichikawa K; Ohkura Y; Ono Y; Imura J; Yamaoka S; Sakamoto C; Ueda Y; Chiba T
Gut; 2004 May; 53(5):710-6. PubMed ID: 15082590
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
20. Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.
Burmer GC; Rabinovitch PS; Loeb LA
Environ Health Perspect; 1991 Jun; 93():27-31. PubMed ID: 1773797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
